IL6 and endometriosis: Yukihiro et al. reported that the intraperitoneal injection of exogenous LPS (2 mg/kg) twice weekly for four weeks significantly enhanced VEGF and IL-6 mRNA levels and increased the percentage of Ki67-positive endometrial gland epithelia and stromal cells in endometriosis-like implants [18].